Aug 28, 2018

Moore's law is getting tougher to follow for chipmakers

A GlobalFoundries factory in Dresden, Germany. Photo: Matthias Rietschel/Getty Images

For decades now, semiconductors have been made using ever-finer wiring, enabling the famous Moore's law, which predicts a doubling of performance every two years or so. But, as transistors have gotten smaller, some chipmakers are struggling to keep up.

Driving the news: The latest shift to 7-nanometer wiring is proving to be the toughest yet. Intel has already admitted challenges and now one of the other industry giants, GlobalFoundries, said Monday it's going to focus on other types of advances rather than moving to 7 nanometers amid the high costs of the new generation.

Analysts say it's not that GlobalFoundries and others can't get to 7 nanometers eventually — it's more whether it would be worth their while.

"The problems are only partially technical — given enough talent and time, foundries can make 7nm and 5nm, and beyond. The problem is the economics — hiring the talented researchers, paying for the research, buying the equipment, and building the fabs. All that is getting exponentially more expensive. GlobalFoundries owners decided the push to 7nm was no longer going to be economically worth the investment."
Kevin Krewell, principal analyst, TIRIAS Research
"This is also proof positive that only a handful of chip companies can afford leading-edge manufacturing as they are the ones who have to pay for the capability."
Patrick Moorhead, president, Moor Insights & Strategy

The bottom line: The challenges give the upper hand to those moving forward with 7 nanometers — namely, TSMC and Samsung. It also leaves those who contract out for manufacturing with just two options.

Go deeper

Special report: War, fever and baseball in 1918

A baseball player wearing a mask in 1918. Photo: George Rinhart/Corbis via Getty Images

In January 1918, the horrors of World War I were in their final year, and Major League Baseball was preparing for its 16th season. But beneath the surface, another deadly battle was brewing. They called it the "Spanish flu."

The state of play: Over the next 15 months, the global pandemic infected an estimated 500 million people — about a quarter of the world's population at the time — and killed as many as 100 million.

Peter Navarro defends hydroxychloroquine use in heated CNN interview

White House economic adviser Peter Navarro defended the use of anti-malarial drug hydroxychloroquine to treat coronavirus during a CNN interview Monday, highlighting "the possibility" that it has therapeutic efficacy.

Why it matters: Navarro did not deny reporting from Axios' Jonathan Swan that he got into a heated exchange in the White House Situation Room over the weekend with infectious disease expert Dr. Anthony Fauci about the drug's prospects against the illness.

Special report: Health care workers vs. coronavirus

Photo Illustration: Sarah Grillo/Axios. Photos: Angela Weiss/AFP via Getty Images, Bruce Bennett/Getty Images, and Europa Press News/Europa Press via Getty Images

Health care workers are at an especially high risk of catching the coronavirus, because of their prolonged exposure to patients who have it. Making matters worse, the U.S. doesn't have enough of the protective equipment, like masks and gloves, that keeps them safe.

  • And yet these workers, with loved ones of their own, keep showing up at hospitals across the country, knowing that more Americans than they can possibly care for are depending on them.
Go deeperArrow53 mins ago - Health